India has so far administered 595,504,593 vaccine doses. That is 1831.62 per cent of its total caseload, and 42.68 per cent of its population
India has so far administered 588,997,805 vaccine doses. That is 1813.7 per cent of its total caseload, and 42.21 per cent of its population
India has so far administered 582,549,595 vaccine doses. That is 1795.26 per cent of its total caseload, and 41.75 per cent of its population
India has so far administered 572,281,488 vaccine doses. That is 1768.48 per cent of its total caseload, and 41.01 per cent of its population
India has so far administered 566,488,433 vaccine doses. That is 1752.62 per cent of its total caseload, and 40.6 per cent of its population
India has so far administered 560,652,030 vaccine doses. That is 1738.41 per cent of its total caseload, and 40.18 per cent of its population
India has so far administered 554,730,609 vaccine doses. That is 1720.05 per cent of its total caseload, and 39.77 per cent of its population
India has so far administered 545,857,108 vaccine doses. That is 1693.86 per cent of its total caseload, and 39.13 per cent of its population
India has so far administered 543,846,290 vaccine doses. That is 1689.35 per cent of its total caseload, and 38.99 per cent of its population
India has so far administered 523,671,019 vaccine doses. That is 1632.5 per cent of its total caseload, and 37.54 per cent of its population
India has so far administered 508,664,759 vaccine doses. That is 1591.07 per cent of its total caseload, and 36.47 per cent of its population
The study was conducted on 18 individuals who inadvertently received Covishield as first jab and Covaxin as second in UP at a gap of six weeks
Provided states don't lift restrictions prematurely and throw caution to the wind, say experts
India has so far administered 506,810,492 vaccine doses. That is 1587.03 per cent of its total caseload, and 36.333 per cent of its population
India has so far administered 489,342,295 vaccine doses. That is 1538.22 per cent of its total caseload, and 35.05 per cent of its population
India has so far administered 478,544,114 vaccine doses. That is 1508.34 per cent of its total caseload, and 34.31 per cent of its population
The study released on Monday showed that Covaxin provides 65.2 per cent protection against the Delta variant which was first detected in India
Bharat Biotech's Covid-19 vaccine Covaxin (BBV152) is effective against Delta Plus (AY.1) variant of the coronavirus, according to a study by the Indian Council of Medical and Research
The domestically developed Covaxin is effective against the Delta plus variant of Covid-19, claims Indian Council of Medical Research (ICMR) in its study released on Monday.
Daily cases have grown persistently through July in Kerala and a few smaller north-eastern states